CN101507756A - Medicine for treating hemiplegia - Google Patents

Medicine for treating hemiplegia Download PDF

Info

Publication number
CN101507756A
CN101507756A CNA2009100199743A CN200910019974A CN101507756A CN 101507756 A CN101507756 A CN 101507756A CN A2009100199743 A CNA2009100199743 A CN A2009100199743A CN 200910019974 A CN200910019974 A CN 200910019974A CN 101507756 A CN101507756 A CN 101507756A
Authority
CN
China
Prior art keywords
medicine
radix
hemiplegia
eupolyphaga
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2009100199743A
Other languages
Chinese (zh)
Inventor
孟宪银
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2009100199743A priority Critical patent/CN101507756A/en
Publication of CN101507756A publication Critical patent/CN101507756A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating hemiplegia, which mainly comprises radix astragali, ramulus mori, pberetima, radix cyathulae, eupolyphaga and safflower according to certain weight proportion. The medicine has the efficacies of nourishing, regulating ying and wei, enhancing immunity, expelling wind and removing toxicity, clearing and activating the channels and collaterals, and clearing heat and releasing toxin, has cure rate reaching 90 percent, cannot easily recrudesce after recovery, and is convenient for taking.

Description

The medicine of treatment hemiplegia
Technical field
The invention belongs to pure technical field of Chinese medicines, is a kind of medicine of the treatment hemiplegia of being made by pure Chinese herbal medicine specifically.
Background technology
Hemiplegia is by hypertension, hyperlipidemia, arteriosclerosis, causes the sequela due to cerebral thrombosis, the cerebral hemorrhage.The cause of disease is the diseases caused by exogenous pathogenic factor ailment said due to cold or exposure, and internal damage by the excessive seven emotions causes battalion to defend imbalance, and hypoimmunity is in ailment said due to cold or exposure is gone into, invade the five internal organs six mansions, cause the five internal organs pathogenic heat, the endocrine disturbance forms hypertension, hyperlipidemia, diseases such as arteriosclerosis worsen the back and become cerebral thrombosis, or cerebral hemorrhage, cause hemiplegia at last.Primary disease is cured the symptoms, not the disease with western medicine, and effect is bad, the expense height, and financial burden is heavy.
The object of the present invention is to provide a kind of pure Chinese medicinal preparation for the treatment of hemiplegia, have good effect, more the back is difficult for recurrence, and low cost and other advantages can reach the purpose for the treatment of hemiplegia.The present invention is formulated by pure Chinese medicine, has no side effect, and takes effect in 20 days with the back, can cure in 3 months.
Summary of the invention
The present invention is achieved in that
The medicine of treatment hemiplegia is characterized in that it being to be made by the following weight Chinese medicinal raw materials:
Radix Astragali 15-65, Ramulus Mori 10-30, Pheretima 5-15, Rhizoma Chuanxiong 5-14, Radix Angelicae Sinensis 4-12, Radix Cyathulae 4-12, eupolyphaga 2-5, Flos Carthami 1-3.Solution of the present invention is based on the pathogeny of hemiplegia, and treatment by Chinese herbs principle, with reference to modern pharmacological research, select pure Chinese medicine composition in the side for use, meet and join part, select promoting blood circulation and breaking stagnation for use according to Chinese Pharmacopoeia and pharmacology, it is eliminating evil to remove wind, the Lip river alive of stimulating the menstrual flow, strengthening by means of tonics class medicine is formed, and reaches the purpose of treatment hemiplegia.Using the present invention, to treat the hemiplegia effect obvious, adopts oral decoction or powder, cures the back and be difficult for recurrence, effective percentage 100%, cure rate 90%.
The present invention has following clinical effectiveness:
1, medicine passes through oral absorption, but promoting blood circulation and breaking stagnation, it is eliminating evil to remove wind, dredge the meridian passage, and the strengthening by means of tonics health improves immunity, makes the hemiplegia symptom, Lock-out.
2, lasting medicine, active force is strong, taking convenience.
3, the hemiplegia symptom that causes applicable to hypertension, hyperlipidemia, arteriosclerosis etc.
4, cure rate height can reach 90%, and is difficult for recurrence.
Pharmacological research of the present invention shows:
Radix Achyranthis Bidentatae: picric acid, flat nontoxic.
Cure mainly the cold-damp flaccidity syndrome and arthralgia syndrome, the extremity spasm, the expulsion qi stagnation blood stasis does aging, and it is impaired to treat taste, invigorating middle warmer, continuous drawing last breath helped the fortune twelve regular channels, is the sufficient the moon of fainting, few cloudy medicine.The modern medicine study Radix Achyranthis Bidentatae: to cardiovascular effect, expansion lower limb vascular, the sick effect in town.Clinical: control coronary heart disease, cerebrovascular accident, kidney is failed duct ligation stone lumbago and skelalgia.(select from " newly organized Compendium of Materia Medica " Li Shizhen (1518-1593 A.D.) work, publish in January, 2005,191 pages of good stone compilings, the Inner Mongol, Chifeng science tech publishing house).
Radix Angelicae Sinensis: sweet, wet, nontoxic.
Control cough, the epidemic disease cold and heat, warming middle-JIAO to relieve pain, tonifying five ZANG-organs, broken congestion, tissue regeneration promoting blood is controlled wind cutting card, and blood disorder and card abdominal mass painful abdominal mass are determined the gastrointestinal cold caused by deficiency.The modern medicine study Radix Angelicae Sinensis: to the cardiovascular system effect, the influence of blood and hemopoietic system is to Immune Effects.Clinical: treatment cardiovascular disease, treatment digestive system disease.(the same the 135th page).
Rhizoma Chuanxiong: Xin Wen, nontoxic.
Wind headache arthralgia due to cold-dampnes in controlling, the joint contraction, the benefit five kinds of over strain is deficient, strong muscles and bones, the mediation blood vessels, broken silt tissue regeneration promoting, the evacuation of pus granulation promoting, main all strains, wind card edema caused by disorder of QI disease, the blood system disease can be treated the headache carbuncle on the back, the liver benefiting blood, dispersing liver-energy, it is dry to moisten liver.The modern medicine study Rhizoma Chuanxiong: antiplatelet aggregation, antithrombotic forms, and reduces the wall of vein leukocyte adhesion, increases the hat blood flow, improves the myocardial ischemia-anoxemia state, and cardiac function is recovered, and improves cerebral blood circulation, blood pressure lowering and antitumaous effect.Clinical: declare numbness, induce sweat, promoting blood circulation by removing wind, the blood stasis dispelling dredge the meridian passage, cerebrovascular and coronary heart disease are controlled in the warming the meridian regulating menstruation.(the same the 136th page).
Pheretima: salty, cold, nontoxic.
Cure mainly: the calentura mania and irritation, breath with cough anxious chronic infantile convulsion, urinary obstruction etc. (the same the 463rd page).
Ramulus Mori, sweet, cool, nontoxic.
Cure mainly: entire body pruritus due to wind pathogen drying, aqueous vapor, beriberi, pathogenic wind, spasm of the limbs, last core fortune, the lung qi cough, the diuresis that helps digestion is made light of one's life by commiting suicide, and makes eye bright to make us gloss, does not have the different clothes of a specified duration of taboo, does not suffer from hemiplegia all the life.(Compendium of Material Medica Li Shizhen (1518-1593 A.D.) work, in July, 2004 version, the 399th page of compiling such as Yu Chiyang, Li Tong, Yi Li publishing house publishes).
Flos Carthami: hot, temperature, nontoxic.
Cure mainly blood fortune locked mouth, stagnant blood is used removing blood stasis not to the utmost in the abdomen, lacks with nourishing blood, and invigorates blood circulation and moisturizes, and pain-relieving powder for treating is swollen, stimulates the menstrual flow.(the same the 112nd page).
Eupolyphaga: cold, salty.
Removing blood stasis with potent drugs is invigorated blood circulation, inducing menstruation to relieve menalgia, main traumatic injury, blood stasis lump in the abdomen.
The Radix Astragali: sweet, tepor, nontoxic.
The cold and heat disease of main TAI YANG syndrome and Yangwei Channel, the QI rising in reverse order pain in the abdomen disease of governor vessel, but QI invigorating, it is deficient to mend the men and women, the five internal organs congestion of dispelling, granulation promoting is enriched blood, Gu Wei table, nourishing the stomach gas, deficient spontaneous perspiration, the skin of dispelling heating and neuralgia.The modern medicine study Radix Astragali: enhancing human body immunity function: antiviral, defying age, anti-stress, reduce thrombosis, reduce platelet adhesion, the hepatoprotective kidney promotes cellular metabolism.Clinical: control tracheitis, heart premature beat, coronary heart disease, gastroenteritis, aplastic anemia, red white corpuscle reduces card, intracranial hematoma.(select from " newly organized Compendium of Materia Medica " Li Shizhen (1518-1593 A.D.) work, publish in January, 2005,191 pages of good stone compilings, the Inner Mongol, Chifeng science tech publishing house).
Drug action mechanism of the present invention is summarized as follows:
With strengthening by means of tonics, transfer battalion to defend, help essence derived from food, the medicine Radix Astragali that improves immunity is a monarch drug; With the Ramulus Mori Ramulus Mori that removes evil medicine that dispels the wind is ministerial drug; Have dredge the meridian passage, nourishing blood and promoting blood circulation, the medicine Radix Cyathulae of heat-clearing and toxic substances removing, Pheretima, Radix Angelicae Sinensis, Rhizoma Chuanxiong are adjuvant drug; Medicine Flos Carthami, eupolyphaga with promote blood circulation to disperse blood clot are messenger drug.All medicines cooperate, and have strengthening the body resistance, and dispel the wind and remove heresy, blood circulation promoting and blood stasis dispelling, the merit of brain-refreshing and channel obstruction-removing reaches the purpose for the treatment of hemiplegia.
The specific embodiment
Embodiment 1, get Radix Astragali 60g, Ramulus Mori 30g, Pheretima 15g, Rhizoma Chuanxiong 14g, Radix Angelicae Sinensis 12g, Radix Cyathulae 12g, eupolyphaga 5g, Flos Carthami 3g, cure mainly the hemiplegia that causes by arteriosclerosis.
Embodiment 2, get Radix Astragali 40g, Ramulus Mori 20g, Pheretima 10g, Rhizoma Chuanxiong 9g, Radix Angelicae Sinensis 8g, Radix Cyathulae 8g, eupolyphaga 3g, Flos Carthami 2g, cure mainly the hemiplegia that causes by hypertension.
Said medicine was soaked 15-20 minute with cold water, boil 30 minutes with low baking temperature, oral, or said medicine made 100 order powder, and oral, every day 3 times, each 8g.
For showing the curative effect of medicine of the present invention, the 100 routine patients that treat are divided into matched group and experimental group, upright shelves stay to be looked into and is added up for this reason, and matched group is treated with routine of western medicine, experimental group Drug therapy of the present invention.Is effectively with the sx, transference cure and not recur be recovery from illness.Statistical result is as follows:
The therapeutic effect synopsis
Table one: matched group effect comparison table
Figure A200910019974D00071
Table two: experimental group curative effect situation
Figure A200910019974D00072

Claims (3)

1, the medicine of treatment hemiplegia, it is characterized in that: it is made by the following weight Chinese medicinal raw materials:
Radix Astragali 15-65 Ramulus Mori 10-30 Pheretima 5-15
Rhizoma Chuanxiong 5-14 Radix Angelicae Sinensis 4-12 Radix Cyathulae 4-12
Eupolyphaga 2-5 Flos Carthami 1-3
2, the medicine of treatment hemiplegia according to claim 1 wherein is characterised in that: the weight proportion of each raw material is:
The Radix Astragali 60 Ramulus Moris 30 Pheretimas 15
Rhizoma Chuanxiong 14 Radix Angelicae Sinensis 12 Radix Cyathulaes 12
Eupolyphaga 5 Flos Carthamis 3
3, the medicine of treatment hemiplegia according to claim 1 wherein is characterised in that: the weight proportion of each raw material is:
The Radix Astragali 40 Ramulus Moris 20 Pheretimas 10
Rhizoma Chuanxiong 9 Radix Angelicae Sinensis 8 Radix Cyathulaes 8
Eupolyphaga 3 Flos Carthamis 2
CNA2009100199743A 2009-03-25 2009-03-25 Medicine for treating hemiplegia Pending CN101507756A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2009100199743A CN101507756A (en) 2009-03-25 2009-03-25 Medicine for treating hemiplegia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2009100199743A CN101507756A (en) 2009-03-25 2009-03-25 Medicine for treating hemiplegia

Publications (1)

Publication Number Publication Date
CN101507756A true CN101507756A (en) 2009-08-19

Family

ID=41000393

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2009100199743A Pending CN101507756A (en) 2009-03-25 2009-03-25 Medicine for treating hemiplegia

Country Status (1)

Country Link
CN (1) CN101507756A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101961459A (en) * 2010-09-22 2011-02-02 孟宪银 Oral medicament for treating hemiplegia
CN103127290A (en) * 2013-03-21 2013-06-05 张治国 Chinese herbal composition for washout treating hand and foot numbness after stroke

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101961459A (en) * 2010-09-22 2011-02-02 孟宪银 Oral medicament for treating hemiplegia
CN103127290A (en) * 2013-03-21 2013-06-05 张治国 Chinese herbal composition for washout treating hand and foot numbness after stroke
CN103127290B (en) * 2013-03-21 2014-07-09 张治国 Chinese herbal composition for washout treating hand and foot numbness after stroke

Similar Documents

Publication Publication Date Title
CN101972453B (en) Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof
CN101766773B (en) Chinese medicine prescription for treating talagia
CN102258658B (en) Plaster for invigorating blood circulation and relieving pain
CN104644943A (en) Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method
CN102512630A (en) Traditional Chinese medicine composition for treating gallbladder calculus
CN103211932B (en) Traditional Chinese medicine composition for treating rheumatism
CN101507802A (en) Medicine for treating ankylosing spondylitis
CN102247497A (en) Chinese patent medicine for treating rheumatoid arthritis
CN101376016B (en) Method for preparing Chinese medicine for treating hyperlipemia
CN102397514A (en) Traditional Chinese medicine for treating rheurnatic diseases
CN103405682A (en) Traditional Chinese medicine for treating gout and preparation method thereof
CN103316223A (en) Neck pain treatment capsules
CN104825561A (en) Traditional Chinese medicine for treating arthritis
CN103977308A (en) Tradition Chinese medicine composition for treating ankylosing spondylitis
CN104107393A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN101507756A (en) Medicine for treating hemiplegia
CN103463304B (en) One treats arthroncus of knee Chinese medicine
CN103341129A (en) External-application medicine for treating sprained ankle
CN102058751A (en) Traditional Chinese medicine for treating chronic infectious arthritis
CN101708324B (en) Plaster used for treating femoral head necrosis and preparation method thereof
CN104958735A (en) Traditional Chinese medicine for treating rheumatic arthritis
CN103463463A (en) Traditional Chinese medicine preparation for replenishing and activating blood and dispelling wind and removing dampness
CN108853452A (en) A kind of Chinese medicine composition preventing and treating rheumatism atrophic arthritis disease
CN100482259C (en) Chinese medicine for treating cervical spondylosis
CN102028916B (en) Thickleaf croton root and clematis root soup for treating lumbocrural pain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090819